Olmesartan Medoxomil is an angiotensin II receptor (AT1) antagonist. This compound also inhibits the negative regulatory feedback on renin secretion. The result of receptor inhibition is vasodilation and a reduction in peripheral resistance.
Olmesartan Medoxomil is an angiotensin II receptor (AT1) antagonist. This compound also inhibits the negative regulatory feedback on renin secretion. The result of receptor inhibition is vasodilation and a reduction in peripheral resistance.
Details |
|
---|---|
Chemical Name |
OLMESARTAN MEDOXOMIL |
IUPAC Name |
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate |
CAS Number |
144689-63-4 |
Molecular Formula |
C24H26N6O3 |
Synonyms |
OMST;CS-866;Olmetec;Benicar;Oimesartan;Olmesartan medoxomil;OLMESARTAN MEDOXIMIL;OlmesartanC29H30N6O6;Sanguisorba officinalis L.;Olmesartan Medoxomil (100 mg) |
Application |
Angiotensin II Receptor Antagonist |